Penn Capital Management Company, LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1158202 PHILADELPHIA, PA

Back to XERS Full portfolio

Position in XERS

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$399,596

+$22,294 QoQ

Shares Held

68,896

+43.3% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Penn Capital Management Company, LLC holds $58,010,317 across 5 Drug Manufacturers - Specialty & Generic names. XERS ranks #5 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	1,196,073	$14,867,187
2	KNSA	Kiniksa Pharmaceuticals International, plc	301,993	$14,540,962
3	HROW	Harrow, Inc.	407,896	$14,382,412
4	ANIP	Ani Pharmaceuticals Inc	179,716	$13,820,160
5	XERS	Xeris Biopharma Holdings, Inc. This page	68,896	$399,596

All Filings in XERS

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$399,596	68,896	+43.3%	Shares	Sole	2026-05-07
2025-12-31	$377,302	48,064	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.